SCHEMBL1123517

SCHEMBL1123517

CC(C)(C)c1ccc(CC(NC(=O)c2ccc(OCCN(Cc3ccccc3)Cc3ccccc3)cc2)C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.64
ITGB3 P05106 4/20 0.56
ITGA2B P08514 3/20 0.56
GPR132 Q9UNW8 2/20 0.52
RAB9A P51151 2/20 0.51
GAA P10253 1/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.51
ITGB1 P05556 2/20 0.51
ITGAV P06756 1/20 0.51
ITGA5 P08648 1/20 0.51
CA1 P00915 2/20 0.48
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
CASP3 P42574 1/20 0.47
SENP7 Q9BQF6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123368 0.91 GPR132 (0.60) PTPN1ITGB3ITGA2BGPR132ITGB1
SCHEMBL1123050 0.90 PTPN1 (0.69) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL1122721 0.89 PTPN1 (0.68) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL1123437 0.88 PTPN1 (0.67) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL1123282 0.83 PTPN1 (0.58) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL7300651 0.83 ITGB3 (0.66) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL8165005 0.82 PTPN1 (0.67) PTPN1RAB9AMEN1ALDH1A1LMNA
SCHEMBL8165003 0.82 PTPN1 (0.67) PTPN1RAB9AMEN1ALDH1A1LMNA
SCHEMBL1122913 0.82 PTPN1 (0.56) PTPN1ITGB3ITGA2BGPR132RAB9A
SCHEMBL11043905 0.79 ITGB3 (0.69) PTPN1ITGB3ITGA2BGPR132RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
CN-1835914-A New benzamides as PPAR[upsilon] modulators S A L V A T LAB SA (ES) 2006-09-20 CN disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG PTPN1 2708/4885ITGB3 1819/4885ITGA2B 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.